selected publications
-
academic article
-
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia.
Clinical Epigenetics.
10.
2018
Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
European Journal Of Haematology.
100.
2018
Late mortality and morbidity among long‐term leukemia survivors with Down syndrome: A nationwide population‐based cohort study.
Pediatric Blood & Cancer.
65.
2018
Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia.
Leukemia.
32.
2018
Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol.
Leukemia.
31.
2017
Cerebellar mutism syndrome in children with brain tumours of the posterior fossa.
BMC Cancer.
17.
2017
Children with low‐risk acute lymphoblastic leukemia are at highest risk of second cancers.
Pediatric Blood & Cancer.
64.
2017
Presenting features and imaging in childhood acute myeloid leukemia with central nervous system involvement.
Pediatric Blood & Cancer.
64.
2017
Role of neuroimaging in children with acute lymphoblastic leukemia and central nervous system involvement at diagnosis.
Pediatric Blood & Cancer.
64.
2017
The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL‐92 and ALL‐2000 protocols.
Pediatric Blood & Cancer.
64.
2017
CMS-06THE NOPHO-EUROPEAN STUDY ON CEREBELLAR MUTISM SYNDROME (CMS).
Neuro-Oncology.
18.
2016
DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T‐Cell Acute Lymphoblastic Leukemia.
Pediatric Blood & Cancer.
63.
2016
Maintenance therapy of childhood acute lymphoblastic leukemia revisited—Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?.
Pediatric Blood & Cancer.
63.
2016
Parents’ and Adolescents’ Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
Pediatric Blood & Cancer.
63.
2016
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
Journal of Thrombosis and Haemostasis.
14.
2016
Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.
Haematologica.
101.
2016
Toxicity profile and treatment delays in NOPHO ALL2008—comparing adults and children with Philadelphia chromosome‐negative acute lymphoblastic leukemia.
European Journal Of Haematology.
96.
2016
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia – a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
British Journal of Haematology.
168.
2015
DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia.
Clinical Epigenetics.
7.
2015
PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Pediatric Blood & Cancer.
62.
2015
A Retrospective Multicenter Study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO) on Cerebral Sinus Venous Thromboses in Children with Acute Lymphoblastic Leukemia.
Blood.
124.
2014
Asparaginase‐associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
British Journal of Haematology.
165.
2014
Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
Pediatric Blood & Cancer.
61.
2014
Complying with the European Clinical Trials directive while surviving the administrative pressure – An alternative approach to toxicity registration in a cancer trial.
European Journal of Cancer.
50.
2014
DNA Methylation-Based Subtype Prediction for Pediatric Acute Lymphoblastic Leukemia (ALL).
Blood.
124.
2014
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer.
Pediatric Blood & Cancer.
61.
2014
Superior Survival Rate Following Conditioning with Etoposide in Childhood ALL.
Biology of Blood and Marrow Transplantation.
20.
2014
The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event‐free survival in the NOPHO ALL92 protocol.
Pediatric Blood & Cancer.
61.
2014
Venous Thromboembolism in Children with Acute Lymphoblastic Leukemia in Northern Europe.
Blood.
124.
2014
-
hide from search
-
Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia.
Leukemia.
2013
Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol.
European Journal Of Haematology.
2013